Sarepta Therapeutics Inc (SRPT)
131.76
-0.06
(-0.05%)
USD |
NASDAQ |
May 13, 16:00
131.76
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics 1 Year Total Returns (Daily): 8.70% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | 8.70% |
May 09, 2024 | 5.53% |
May 08, 2024 | 4.55% |
May 07, 2024 | 3.85% |
May 06, 2024 | 3.08% |
May 03, 2024 | 6.56% |
May 02, 2024 | 5.61% |
May 01, 2024 | 4.63% |
April 30, 2024 | 3.17% |
April 29, 2024 | 4.91% |
April 26, 2024 | 5.31% |
April 25, 2024 | 3.32% |
April 24, 2024 | -1.92% |
April 23, 2024 | -8.49% |
April 22, 2024 | -8.61% |
April 19, 2024 | -6.85% |
April 18, 2024 | -7.17% |
April 17, 2024 | -5.85% |
April 16, 2024 | -4.35% |
April 15, 2024 | -3.52% |
April 12, 2024 | -10.76% |
April 11, 2024 | -10.53% |
April 10, 2024 | -10.02% |
April 09, 2024 | -10.92% |
April 08, 2024 | -11.34% |
Date | Value |
---|---|
April 05, 2024 | -8.33% |
April 04, 2024 | -9.23% |
April 03, 2024 | -7.73% |
April 02, 2024 | -7.86% |
April 01, 2024 | -6.84% |
March 28, 2024 | -3.32% |
March 27, 2024 | -0.69% |
March 26, 2024 | -1.49% |
March 25, 2024 | -1.73% |
March 22, 2024 | -1.22% |
March 21, 2024 | -4.75% |
March 20, 2024 | -4.03% |
March 19, 2024 | 1.12% |
March 18, 2024 | 1.04% |
March 15, 2024 | -15.41% |
March 14, 2024 | -14.59% |
March 13, 2024 | -14.58% |
March 12, 2024 | -15.23% |
March 11, 2024 | -15.52% |
March 08, 2024 | -18.69% |
March 07, 2024 | -22.38% |
March 06, 2024 | -22.87% |
March 05, 2024 | -21.05% |
March 04, 2024 | -20.39% |
March 01, 2024 | -11.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.62%
Minimum
Jul 19 2021
138.3%
Maximum
May 15 2023
4.97%
Average
0.95%
Median
1 Year Total Returns (Daily) Benchmarks
PTC Therapeutics Inc | -43.30% |
Regenxbio Inc | -19.83% |
Catalyst Pharmaceuticals Inc | -8.97% |
Pfizer Inc | -21.89% |
Solid Biosciences Inc | 67.58% |